Plasma Proteins after Continuous, Oral Use of a Progestogen—Chloromadionone Acetate—as a Contraceptive

C. B. Laurell Dept. of Clinical Chemistry, University of Lund, Malmö General Hospital, Malmö, Sweden

S. Kullander Dept. of Clinical Chemistry, University of Lund, Malmö General Hospital, Malmö, Sweden

J. Thorell Dept. of Obstetrics and Gynaecology, University of Lund, Malmö General Hospital, Malmö, Sweden

Abstract

Daily, oral intake of 0.5 mg chloromadionone acetate for contraceptive purpose does not alter the homeostasis of 17 plasma proteins studied. This contrasts with earlier findings after intake of contraceptive pills containing estrogens.

Key Words:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Plasma Proteins after Continuous, Oral Use of a Progestogen—Chloromadionone Acetate—as a Contraceptive

Information for

Open access

Opportunities

Help and information

Plasma Proteins after Continuous, Oral Use of a Progestogen—Chloromadionone Acetate—as a Contraceptive

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature